Daniel R. Chevallard, CFO and COO at Viracta Therapeutics, Inc. (VIRX), sold 3,405 shares at $0.73 ($2K) on 2024-02-27, disclosed to the SEC on 2024-02-27.
Open-market sale of $2k VIRX by CFO and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LENZ | BUY | 2024-05-15 | $50K | — | Filing → |
| VIRX | SELL | 2023-11-28 | $2K | — | Filing → |
| VIRX | SELL | 2023-08-29 | $5K | — | Filing → |